Stentrode
Provider Synchronsynchron.com130M raised · Series C
Founded 2016
Sells To Enterprise
Pricing Model Software
Ownership Equity, Venture Capital
Endovascular brain-computer interface implanted via the jugular vein, decoding motor cortex signals without open-skull surgery.
The Stentrode system combines three hardware components: an endovascular electrode array seated in a cortical blood vessel to detect neural firing patterns; an Internal Receiver Transmitter (IRT) implanted in the chest; and an external Signal Processing Unit (SPU) that decodes motor intent and routes commands to a paired smartphone or tablet. Because the array is delivered through the jugular vein, the procedure resembles stent placement rather than conventional neurosurgery, eliminating the need for a craniotomy.
The system is designed for people living with tetraplegia who retain motor intent but have lost the physical pathways to act on it. By translating cortical signals into digital inputs, it enables users to schedule appointments, send messages, and conduct online transactions via thought-driven touchscreen control; the technology carries investigational status under U.S. federal law and is being evaluated in ongoing clinical trials.
| Attribute | Stentrode | MoveAgain BCI, NeuroPort Array | |
|---|---|---|---|
| Provider | |||
| Founded | 2016 | 2008 | |
| Sells To | Enterprise | Enterprise, Government | |
| Pricing Model | Software | Recurring, Transactional | |
| Ownership | Equity, Venture Capital | Private |
Provider Synchronsynchron.com130M raised · Series C
Founded 2016
Sells To Enterprise
Pricing Model Software
Ownership Equity, Venture Capital
Provider 
Founded 2008
Sells To Enterprise, Government
Pricing Model Recurring, Transactional
Ownership Private

Layer 7 Cortical Interface
precisionneuro.io